Arca
Skip to content
Tools
Tools

-denoson

Drugs that activate adenosine receptors.

  • Drugs ending in -denoson: 11
  • Approved somewhere: 1
  • With a US drug page: 0

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-denoson
Class
Drugs that activate adenosine receptors
Most common targets
ADORA2A (5), ADORA1 (4), ADORA3 (2)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -denoson, matched by spelling; those with a US drug page link to it.
Acts on
Regadenoson anhydrousApprovedADORA2AAdenosine A2a receptor agonist
PiclidenosonPhase 3ADORA3Adenosine A3 receptor agonist
TrabodenosonPhase 3ADORA1Adenosine A1 receptor agonist
CapadenosonPhase 2ADORA1Adenosine A1 receptor partial agonist
NamodenosonPhase 2ADORA3Adenosine A3 receptor agonist
SelodenosonPhase 2ADORA1Adenosine A1 receptor agonist
SonedenosonPhase 2ADORA2AAdenosine A2a receptor agonist
TecadenosonPhase 2ADORA1Adenosine A1 receptor agonist
EvodenosonPhase 1ADORA2AAdenosine A2a receptor agonist
Apadenoson—ADORA2AAdenosine A2a receptor agonist
Binodenoson—ADORA2AAdenosine A2a receptor agonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.